Log in to save to my catalogue

Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted k...

Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted k...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c77301ce65e04d2186c72f154ca8d349

Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet

About this item

Full title

Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet

Publisher

England: BioMed Central Ltd

Journal title

Nutrition & metabolism, 2008-11, Vol.5 (1), p.33-33, Article 33

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Astrocytomas are largely dependent on glycolysis to satisfy their bioenergetic requirements for growth and survival. Therapies that target glycolysis can potentially manage astrocytoma growth and progression. Dietary restriction of the high fat/low carbohydrate ketogenic diet (KD-R) reduces glycolysis and is effective in managing experimental mouse...

Alternative Titles

Full title

Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c77301ce65e04d2186c72f154ca8d349

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c77301ce65e04d2186c72f154ca8d349

Other Identifiers

ISSN

1743-7075

E-ISSN

1743-7075

DOI

10.1186/1743-7075-5-33

How to access this item